Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 7
1995 11
1996 47
1997 94
1998 103
1999 139
2000 185
2001 127
2002 136
2003 143
2004 156
2005 216
2006 223
2007 236
2008 231
2009 236
2010 252
2011 225
2012 264
2013 243
2014 235
2015 220
2016 200
2017 197
2018 164
2019 110
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

3,942 results
Results by year
Filters applied: . Clear all
Page 1
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.
Carlsson AC, Ruge T, Kjøller E, Hilden J, Kolmos HJ, Sajadieh A, Kastrup J, Jensen GB, Larsson A, Nowak C, Jakobsen JC, Winkel P, Gluud C, Ärnlöv J. Carlsson AC, et al. J Am Heart Assoc. 2018 Apr 23;7(9):e008299. doi: 10.1161/JAHA.117.008299. J Am Heart Assoc. 2018. PMID: 29686027 Free PMC article. Clinical Trial.
Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers.
Caram LMO, Ferrari R, Nogueira DL, Oliveira M, Francisqueti FV, Tanni SE, Corrêa CR, Godoy I. Caram LMO, et al. Int J Chron Obstruct Pulmon Dis. 2017 Jul 7;12:2015-2021. doi: 10.2147/COPD.S138558. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28744116 Free PMC article.
3,942 results
Jump to page
Feedback